Cancer treatment has evolved significantly with the introduction of targeted therapies, offering patients more precise and effective treatment options. Olaparib 100mg and 150mg Tablets have emerged as a groundbreaking medication for patients diagnosed with specific genetic mutations associated with various cancers.
Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical company committed to manufacturing and exporting high-quality Olaparib 100mg and Olaparib 150mg Tablets to global markets, including Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Olaparib?
Olaparib is an oral PARP (Poly ADP-Ribose Polymerase) inhibitor used to treat several types of cancers associated with BRCA1 and BRCA2 gene mutations.
It works by preventing cancer cells from repairing damaged DNA, ultimately causing cancer cell death while minimizing damage to healthy cells.
Therapeutic Uses of Olaparib 100mg/150mg Tablets
Olaparib is prescribed for:
1. Advanced Ovarian Cancer Treatment
Maintenance treatment for recurrent ovarian cancer
BRCA-mutated ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer
2. HER2-Negative Breast Cancer
Used in patients with inherited BRCA mutations.
3. Metastatic Pancreatic Cancer
Maintenance therapy for patients responding to platinum-based chemotherapy.
4. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recommended for patients with HRR gene mutations.
Key Benefits of Olaparib Tablets
✅ Precision-targeted cancer therapy
✅ Improves progression-free survival
✅ Delays cancer recurrence
✅ Oral tablet administration
✅ Reduces dependency on conventional chemotherapy
✅ Personalized treatment approach
✅ Better quality of life for eligible patients
Available Strengths
Olaparib 100mg Tablets
Easy dose adjustment
Suitable for personalized treatment plans
Physician-supervised administration
Olaparib 150mg Tablets
Standard therapeutic strength
Widely prescribed globally
Used for long-term maintenance therapy
Dosage should only be determined by qualified oncologists.
How Does Olaparib Work?
Olaparib blocks the PARP enzyme responsible for repairing DNA damage in cancer cells.
Patients with BRCA mutations already have impaired DNA repair mechanisms. By inhibiting PARP, Olaparib causes cancer cells to accumulate DNA damage and eventually die.
This process is known as synthetic lethality, making Olaparib a highly effective precision oncology treatment.
Common Side Effects
Patients may experience:
Nausea
Fatigue
Vomiting
Anemia
Loss of appetite
Diarrhea
Headache
Dizziness
Reduced blood cell counts
Patients should always follow medical supervision during treatment.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is committed to delivering affordable, high-quality oncology medicines globally.
Our Advantages
✔ WHO-GMP compliant manufacturing
✔ Stringent quality control systems
✔ International export capabilities
✔ Competitive pricing
✔ Reliable supply chain management
✔ Regulatory documentation support
✔ Dedicated global distribution network
Countries We Export To
We actively serve oncology medicine partners, hospitals, distributors, and healthcare organizations in:
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇵🇭 Philippines
🇻🇳 Vietnam
🇦🇪 UAE
🇸🇦 Saudi Arabia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
🇺🇸 USA
🇬🇧 UK
🇿🇦 South Africa
Frequently Asked Questions (FAQs)
Is Olaparib chemotherapy?
No. Olaparib is a targeted therapy known as a PARP inhibitor, not conventional chemotherapy.
Who can take Olaparib?
Patients with specific BRCA or HRR gene mutations, as determined by oncologists and genetic testing.
Is Olaparib available globally?
Yes. Cordium Pharmaceuticals Pvt Ltd supports international supply and export operations in multiple countries.
Can Olaparib cure cancer?
Olaparib is not considered a cure but helps control disease progression, delay recurrence, and improve survival outcomes.
Contact Cordium Pharmaceuticals Pvt Ltd
Your Trusted Global Oncology Partner
Product: Olaparib 100mg Tablets | Olaparib 150mg Tablets
Category: Oncol
